<DOC>
	<DOCNO>NCT00474916</DOCNO>
	<brief_summary>The purpose study collect begin information whether intravenous ( IV ) administration KRN5500 safe effective treatment neuropathic pain patient cancer .</brief_summary>
	<brief_title>Neuropathic Pain Patients With Cancer</brief_title>
	<detailed_description>Neuropathic pain type pain result nerve damage characterize abnormal hypersensitivity harmless well harmful stimulus . This type pain extremely difficult manage , fail respond standard analgesic medication intervention , often get bad instead good time . Current approve therapeutic agent often intolerable side effect limit efficacy . Thus , urgent need develop safe effective drug treat neuropathic pain . Study DTCL100 conduct multiple center enroll patient advanced cancer AND neuropathic pain respond well previous treatment . Eighteen patient randomly assign receive 8 dos active drug ( KRN5500 ) placebo . A maximum 8 dos administer weekly 10 week period . Patients encourage complete least 4 treatment visit decision make complete full 10 week treatment 1 month followup period .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<criteria>18 year old Diagnosis advance recurrent cancer No option curative chemotherapy , palliative chemotherapy allow certain condition Refractory neuropathic pain rat 4 great 010 scale failure respond 2 commonly use treatment If take opioids pain , stable regimen past week enrol Karnofsky performance status 40 Females must sterile postmenopausal Radiation site neuropathic pain past 4 week Major surgery within past 2 week Liver function key lab outside normal parameter ECG show significant abnormality Myocardial Infarction ( heart attack ) within past 6 month History interstitial lung disease History severe allergic reaction drug contain polysorbate 80 Other investigational drug within 2 week 5 halflives ( whichever longer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Neuropathic pain</keyword>
	<keyword>Cancer</keyword>
</DOC>